1Q: Roanoke Asset Management reduces stake in Eli Lilly by 13.0%, while LLY Q4 EPS beats estimates.
During Q3, Roanoke Asset Management Corp NY reduced its stake in Eli Lilly and Co (LLY) by 13.0% to 13,495 shares, accounting for 3.0% of its portfolio. Other institutional investors also made changes to their holdings in LLY, with some increasing their stakes. LLY reported better-than-expected Q4 EPS of $2.49, exceeding analysts' estimates of $2.30 and revenue reaching $9.35 billion, surpassing expectations of $8.95 billion.
March 07, 2024
8 Articles